Physician profile
Michael Fletcher
NPI 1063476216
$17,970.62
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.48 · 2020: $8,261 · 2021: $9,657.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $9,546.71 | 2021 | |
| Mdd US Operations, LLC | $8,260.56 | 2020 | |
| Biodelivery Sciences International, INC. | $40.49 | 2021 | |
| Grt US Holding, INC. | $36.45 | 2021 | |
| Indivior INC. | $25.09 | 2019 | |
| Bioventus LLC | $18.38 | 2021 | |
| Titan Pharmaceuticals, INC. | $17.35 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.55 | 2021 | |
| Orexo US, INC. | $11.04 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fletcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.